What is the projected market valuation of Montelukast Sodium by 2035?

The projected market valuation of Montelukast Sodium is expected to reach 3.715 USD Billion by 2035. Read More

What was the market valuation of Montelukast Sodium in 2024?

The overall market valuation of Montelukast Sodium was 2.066 USD Billion in 2024. Read More

What is the expected CAGR for the Montelukast Sodium Market from 2025 to 2035?

The expected CAGR for the Montelukast Sodium Market during the forecast period 2025 - 2035 is 5.48%. Read More

Which companies are the key players in the Montelukast Sodium Market?

Key players in the Montelukast Sodium Market include Merck & Co., Teva Pharmaceutical Industries Ltd., and Mylan N.V. Read More

What are the main applications of Montelukast Sodium and their market values?

The main applications include Asthma, valued at 1.482 USD Billion, Allergic Rhinitis at 1.12 USD Billion, and Exercise-Induced Bronchoconstriction at 1.113 USD Billion. Read More

How does the market for Montelukast Sodium's formulations break down?

The market for formulations includes Tablets at 1.6 USD Billion, Granules at 0.7 USD Billion, and Chewable Tablets at 0.9 USD Billion. Read More

What distribution channels are utilized for Montelukast Sodium?

Distribution channels include Hospital Pharmacies at 1.482 USD Billion, Retail Pharmacies at 1.347 USD Billion, and Online Pharmacies at 0.886 USD Billion. Read More

What are the end-use segments for Montelukast Sodium and their respective market values?

End-use segments include Hospitals at 1.487 USD Billion, Clinics at 1.115 USD Billion, and Home Care at 1.113 USD Billion. Read More

How does the market for Montelukast Sodium appear to be evolving?

The Montelukast Sodium Market appears to be evolving positively, with a projected increase in valuation and steady growth rates. Read More

What factors might influence the growth of the Montelukast Sodium Market in the coming years?

Factors influencing growth may include increasing prevalence of asthma and allergic conditions, alongside advancements in formulation and distribution. Read More

Montelukast Sodium Market

ID: MRFR/HC/31899-HCR

128 Pages

Rahul Gotadki

Last Updated: May 15, 2026

Montelukast Sodium Market Research Report By Application (Asthma, Allergic Rhinitis, Exercise-Induced Bronchoconstriction), By Formulation (Tablets, Granules, Chewable Tablets, Oral Solution), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End Use (Hospitals, Clinics, Home Care) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Billion)
  1. 4.1.1 Asthma
  2. 4.1.2 Allergic Rhinitis
  3. 4.1.3 Exercise-Induced Bronchoconstriction
2. 4.2 Healthcare, BY Formulation (USD Billion)
  1. 4.2.1 Tablets
  2. 4.2.2 Granules
  3. 4.2.3 Chewable Tablets
  4. 4.2.4 Oral Solution
3. 4.3 Healthcare, BY Distribution Channel (USD Billion)
  1. 4.3.1 Hospital Pharmacies
  2. 4.3.2 Retail Pharmacies
  3. 4.3.3 Online Pharmacies
4. 4.4 Healthcare, BY End-Use (USD Billion)
  1. 4.4.1 Hospitals
  2. 4.4.2 Clinics
  3. 4.4.3 Home Care
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Merck & Co. (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Teva Pharmaceutical Industries Ltd. (IL)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Mylan N.V. (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Sandoz International GmbH (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 AstraZeneca PLC (GB)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Hikma Pharmaceuticals PLC (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Sun Pharmaceutical Industries Ltd. (IN)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Zydus Cadila (IN)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY FORMULATION
5. 6.5 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 US MARKET ANALYSIS BY END-USE
7. 6.7 CANADA MARKET ANALYSIS BY APPLICATION
8. 6.8 CANADA MARKET ANALYSIS BY FORMULATION
9. 6.9 CANADA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
10. 6.10 CANADA MARKET ANALYSIS BY END-USE
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY APPLICATION
13. 6.13 GERMANY MARKET ANALYSIS BY FORMULATION
14. 6.14 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
15. 6.15 GERMANY MARKET ANALYSIS BY END-USE
16. 6.16 UK MARKET ANALYSIS BY APPLICATION
17. 6.17 UK MARKET ANALYSIS BY FORMULATION
18. 6.18 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
19. 6.19 UK MARKET ANALYSIS BY END-USE
20. 6.20 FRANCE MARKET ANALYSIS BY APPLICATION
21. 6.21 FRANCE MARKET ANALYSIS BY FORMULATION
22. 6.22 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
23. 6.23 FRANCE MARKET ANALYSIS BY END-USE
24. 6.24 RUSSIA MARKET ANALYSIS BY APPLICATION
25. 6.25 RUSSIA MARKET ANALYSIS BY FORMULATION
26. 6.26 RUSSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
27. 6.27 RUSSIA MARKET ANALYSIS BY END-USE
28. 6.28 ITALY MARKET ANALYSIS BY APPLICATION
29. 6.29 ITALY MARKET ANALYSIS BY FORMULATION
30. 6.30 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
31. 6.31 ITALY MARKET ANALYSIS BY END-USE
32. 6.32 SPAIN MARKET ANALYSIS BY APPLICATION
33. 6.33 SPAIN MARKET ANALYSIS BY FORMULATION
34. 6.34 SPAIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
35. 6.35 SPAIN MARKET ANALYSIS BY END-USE
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY FORMULATION
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY END-USE
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY APPLICATION
42. 6.42 CHINA MARKET ANALYSIS BY FORMULATION
43. 6.43 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
44. 6.44 CHINA MARKET ANALYSIS BY END-USE
45. 6.45 INDIA MARKET ANALYSIS BY APPLICATION
46. 6.46 INDIA MARKET ANALYSIS BY FORMULATION
47. 6.47 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
48. 6.48 INDIA MARKET ANALYSIS BY END-USE
49. 6.49 JAPAN MARKET ANALYSIS BY APPLICATION
50. 6.50 JAPAN MARKET ANALYSIS BY FORMULATION
51. 6.51 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
52. 6.52 JAPAN MARKET ANALYSIS BY END-USE
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY FORMULATION
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY END-USE
57. 6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION
58. 6.58 MALAYSIA MARKET ANALYSIS BY FORMULATION
59. 6.59 MALAYSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
60. 6.60 MALAYSIA MARKET ANALYSIS BY END-USE
61. 6.61 THAILAND MARKET ANALYSIS BY APPLICATION
62. 6.62 THAILAND MARKET ANALYSIS BY FORMULATION
63. 6.63 THAILAND MARKET ANALYSIS BY DISTRIBUTION CHANNEL
64. 6.64 THAILAND MARKET ANALYSIS BY END-USE
65. 6.65 INDONESIA MARKET ANALYSIS BY APPLICATION
66. 6.66 INDONESIA MARKET ANALYSIS BY FORMULATION
67. 6.67 INDONESIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
68. 6.68 INDONESIA MARKET ANALYSIS BY END-USE
69. 6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION
70. 6.70 REST OF APAC MARKET ANALYSIS BY FORMULATION
71. 6.71 REST OF APAC MARKET ANALYSIS BY DISTRIBUTION CHANNEL
72. 6.72 REST OF APAC MARKET ANALYSIS BY END-USE
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY APPLICATION
75. 6.75 BRAZIL MARKET ANALYSIS BY FORMULATION
76. 6.76 BRAZIL MARKET ANALYSIS BY DISTRIBUTION CHANNEL
77. 6.77 BRAZIL MARKET ANALYSIS BY END-USE
78. 6.78 MEXICO MARKET ANALYSIS BY APPLICATION
79. 6.79 MEXICO MARKET ANALYSIS BY FORMULATION
80. 6.80 MEXICO MARKET ANALYSIS BY DISTRIBUTION CHANNEL
81. 6.81 MEXICO MARKET ANALYSIS BY END-USE
82. 6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION
83. 6.83 ARGENTINA MARKET ANALYSIS BY FORMULATION
84. 6.84 ARGENTINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
85. 6.85 ARGENTINA MARKET ANALYSIS BY END-USE
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USE
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USE
99. 6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION
100. 6.100 REST OF MEA MARKET ANALYSIS BY FORMULATION
101. 6.101 REST OF MEA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
102. 6.102 REST OF MEA MARKET ANALYSIS BY END-USE
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY FORMULATION, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY FORMULATION, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY END-USE, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.2.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.2.4 BY END-USE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.3.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.3.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.3.4 BY END-USE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.4.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.4.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.4.4 BY END-USE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.5.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.5.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.5.4 BY END-USE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.6.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.6.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.6.4 BY END-USE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.7.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.7.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.7.4 BY END-USE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.8.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.8.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.8.4 BY END-USE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.9.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.9.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.9.4 BY END-USE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.10.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.10.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.10.4 BY END-USE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.11.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.11.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.11.4 BY END-USE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.12.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.12.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.12.4 BY END-USE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.13.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.13.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.13.4 BY END-USE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.14.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.14.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.14.4 BY END-USE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.15.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.15.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.15.4 BY END-USE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.16.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.16.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.16.4 BY END-USE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.17.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.17.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.17.4 BY END-USE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.18.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.18.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.18.4 BY END-USE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.19.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.19.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.19.4 BY END-USE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.20.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.20.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.20.4 BY END-USE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.21.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.21.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.21.4 BY END-USE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.22.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.22.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.22.4 BY END-USE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.23.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.23.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.23.4 BY END-USE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.24.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.24.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.24.4 BY END-USE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.25.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.25.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.25.4 BY END-USE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.26.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.26.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.26.4 BY END-USE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.27.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.27.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.27.4 BY END-USE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.28.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.28.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.28.4 BY END-USE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.29.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.29.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.29.4 BY END-USE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.30.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.30.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.30.4 BY END-USE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Montelukast Sodium Market Segmentation

Montelukast Sodium Market By Application (USD Billion, 2025-2035)

Asthma
Allergic Rhinitis
Exercise-Induced Bronchoconstriction

Montelukast Sodium Market By Formulation (USD Billion, 2025-2035)

Tablets
Granules
Chewable Tablets
Oral Solution

Montelukast Sodium Market By Distribution Channel (USD Billion, 2025-2035)

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Montelukast Sodium Market By End-Use (USD Billion, 2025-2035)

Hospitals
Clinics
Home Care

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”